首页|墨旱莲及蟛蜞菊内酯抗骨质疏松研究进展

墨旱莲及蟛蜞菊内酯抗骨质疏松研究进展

扫码查看
骨质疏松症(osteoporosis,OP)是一种常见的骨代谢疾病,以骨量减少、骨微观结构改变、易发生骨折为特征的骨质病变.目前,西药治疗OP往往会引起不同程度的不良反应,中药治疗OP具有一定优势和特色.以中医理论"肾主骨生髓"为指导,补肾中药常用于临床治疗OP,效果显著.墨旱莲(Ecliptae Herba)为滋补肝肾的传统中药.新近研究表明,墨旱莲及其主要成分蟛蜞菊内酯具有良好的抗骨质疏松作用.对墨旱莲及蟛蜞菊内酯防治OP的骨形成、骨吸收作用及潜在分子机制进行综述,旨在为墨旱莲及蟛蜞菊内酯的临床应用与开发提供借鉴.
Research Progress of Mohanlian(Ecliptae Herba)and Wedelolactone in Anti-Osteoporosis
Osteoporosis(OP)is a common bone metabolic disease characterized by reduced bone mass,changes in bone mi-crostructure and susceptibility to fractures.At present,western medicine treatment often causes different degrees of adverse reac-tions.Traditional Chinese medicine has certain advantages and characteristics in the treatment of OP.Guided by the theory of traditional Chinese medicine"kidney governing bone marrow",kidney-tonifying Chinese drugs are often used in clinical treat-ment of OP,and the effect is significant.Mohanlian(Ecliptae Herba)is a traditional Chinese drug for nourishing liver and kid-ney.Recent studies shows that Mohanlian(Ecliptae Herba)and its main component wedelolactone has good anti-osteoporosis effects.In this paper,the bone formation,bone resorption effects and potential molecular mechanisms of Mohanlian(Ecliptae Her-ba)and wedelolactone in the prevention and treatment of OP were reviewed,aiming to provide a reference for the clinical applica-tion and development of Mohanlian(Ecliptae Herba)and wedelolactone.

Mohanlian(Ecliptae Herba)wedelolactoneosteoporosismolecular mechanismsignal pathway

马毓、赵翔凤、杨素文、魏君、刘艳秋

展开 >

山东中医药大学中医学院,山东济南 250355

墨旱莲 蟛蜞菊内酯 骨质疏松 分子机制 信号通路

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(9)